2-73451669-T-G
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001378454.1(ALMS1):c.5142T>G(p.Tyr1714*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,613,928 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001378454.1 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152102Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249096Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135124
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461826Hom.: 0 Cov.: 39 AF XY: 0.0000179 AC XY: 13AN XY: 727214
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152102Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74302
ClinVar
Submissions by phenotype
Alstrom syndrome Pathogenic:6
- -
- -
This sequence change creates a premature translational stop signal (p.Tyr1715*) in the ALMS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALMS1 are known to be pathogenic (PMID: 17594715). This variant is present in population databases (rs772136379, gnomAD 0.004%). This premature translational stop signal has been observed in individuals with ALMS1-related conditions (PMID: 22876109, 25846608, 28432734). ClinVar contains an entry for this variant (Variation ID: 212728). For these reasons, this variant has been classified as Pathogenic. -
- -
- -
- -
not provided Pathogenic:2
- -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Observed with a second variant on the opposite allele (in trans) in a patient with a clinical diagnosis of Alstrom syndrome (PMID: 22876109); This variant is associated with the following publications: (PMID: 32870709, 22876109, 32531858) -
Retinal dystrophy, early-onset severe Pathogenic:1
- -
Cardiovascular phenotype Pathogenic:1
The p.Y1715* pathogenic mutation (also known as c.5145T>G), located in coding exon 8 of the ALMS1 gene, results from a T to G substitution at nucleotide position 5145. This changes the amino acid from a tyrosine to a stop codon within coding exon 8. This mutation has been reported to co-occur with other mutations in the ALMS1 gene in several individuals with Alstrom syndrome (Piñeiro-Gallego T et al. Mol Vis, 2012 Jul;18:1794-802; Citton V et al. J Neuroradiol, 2016 Jun;43:195-9; Astuti D et al. Hum Mutat, 2017 07;38:764-777; Dotan G et al. Ophthalmic Genet 2017 Jan;38:440-445; Han JC et al. J Clin Endocrinol Metab, 2018 07;103:2707-2719). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at